Central Meditation and Imagery Therapy for Augmentation of Borderline Personality Disorder Treatment

Sponsor
University of California, San Francisco (Other)
Overall Status
Completed
CT.gov ID
NCT02125942
Collaborator
(none)
15
1
2
17
0.9

Study Details

Study Description

Brief Summary

Borderline personality disorder is a severe psychiatric disorder marked by emotional instability, difficulty with interpersonal relationships, and self-harming behaviors. Despite receiving psychotherapy for borderline personality disorder, studies show that patient recovery is slow, and there is a high rate of self injury and suicide attempts early in treatment. There is thus a clear need to provide therapies to augment psychotherapy. We will conduct a pilot trial to determine whether a 6-week Central Meditation and Imagery Therapy (CMIT) is feasible for subjects with borderline personality disorder to undergo when added on to psychotherapy treatment. CMIT is a non-validated therapy that combines principles of mindfulness with meditation techniques and guided imagery. Sessions led by a trained clinician in a group setting once a week, and participants are asked to complete daily home practice.

The trial will involve 16 participants, all currently undergoing psychotherapy for borderline personality disorder. Participants will be randomly assigned to either a CMIT group that lasts 6 weeks, or a wait list group. Those in the wait list group will be able to receive CMIT after 6 weeks. All participants will continue to receive psychotherapy throughout the trial.

During the trial, we will also obtain preliminary data to help understand whether CMIT may result in psychological benefits for participants. This will include measuring the pulse in order to determine variation in beat to beat intervals of the heart during psychological tests, and filling out questionnaires before and after participation in CMIT.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Central Meditation and Imagery Therapy
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Pilot Study of Central Meditation and Imagery Therapy for Borderline Personality Disorder
Study Start Date :
Apr 1, 2014
Actual Primary Completion Date :
Sep 1, 2015
Actual Study Completion Date :
Sep 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: meditation

Central Meditation and Imagery Therapy

Behavioral: Central Meditation and Imagery Therapy
mindfulness, guided imagery, meditation

No Intervention: wait list

waiting list

Outcome Measures

Primary Outcome Measures

  1. Borderline Symptoms [6 weeks]

    Borderline Symptom List

Secondary Outcome Measures

  1. Depression [6 weeks]

    Quick Inventory of Depressive Symptoms

  2. Anxiety [6 weeks]

    Trait Anxiety Inventory

  3. Positive Affect [6 weeks]

    Positive and Negative Affect Scale

Other Outcome Measures

  1. Heart rate variability [6 weeks]

    Resting heart rate variability

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Meeting the diagnostic criteria for BPD according to DSM-IV criteria

  • Meeting the diagnostic criteria for BPD based on the Diagnostic Interview for Borderline - Revised

  • Currently receiving psychotherapy.

  • English language proficiency to understand written and oral communication

Exclusion Criteria:
  • Active suicidality or suicidal intent as identified on the Columbia Suicide Severity Rating Scale

  • Suicide attempt within the past month

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of California, Los Angeles Los Angeles California United States 90095

Sponsors and Collaborators

  • University of California, San Francisco

Investigators

  • Principal Investigator: Felipe A Jain, MD, University of California, Los Angeles

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT02125942
Other Study ID Numbers:
  • CMIT1044
First Posted:
Apr 29, 2014
Last Update Posted:
Jan 13, 2021
Last Verified:
Jan 1, 2021
Keywords provided by University of California, San Francisco
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 13, 2021